The chips are down 'almost' for IBM Blue Gene project
18 February, 2002 by Tanya HollisOne of IT giant IBM's key researchers was in Australia this week to tout the progress of the company's $US100 million Blue Gene project.
Research and business meet on new Cerylid board
18 February, 2002 by Melissa TrudingerCerylid Biosciences has appointed a scientific advisory board made up of big players from the biotech and pharmaceutical sectors.
Optiscan strikes 'company-making' deal with Pentax
18 February, 2002 by Tanya HollisOptiscan Imaging's flexible confocal microscope technology is to be developed and commercialised by marketed by Asahi Optical in a $20 million deal.
